CHRISTY BROWN: Open Payments
NPI 1811728983 · ROANOKE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$550 in 7 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $105 · 2025 $550
Food & beverage: $550
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 2 | $171 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $111 |
| Merck Sharp & Dohme LLC | 1 | $110 |
| ARGENX US, INC. | 1 | $88 |
| AstraZeneca Pharmaceuticals LP | 1 | $51 |
| Neurocrine BioSciences, Inc. | 1 | $18 |
Products named: OTEZLA, CAPLYTA, CAPVAXIVE, VYVGART, BREZTRI, INGREZZA.
Industry payments across VA — which companies pay providers there.
